<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03298178</url>
  </required_header>
  <id_info>
    <org_study_id>AMCCV 2017-09</org_study_id>
    <nct_id>NCT03298178</nct_id>
  </id_info>
  <brief_title>ASAN Medical Center Aortic Valve Replacement Registry</brief_title>
  <acronym>ASAN-AVR</acronym>
  <official_title>ASAN Medical Center Aortic Valve Replacement Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Suk Jung Choo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>CardioVascular Research Foundation, Korea</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Asan Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the effectiveness and safety of surgical aortic valve replacement and
      transcatheter aortic valve replacement in aortic Stenosis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      All TAVR and SAVR cases will be enrolled retrospectively and prospectively.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 1, 2017</start_date>
  <completion_date type="Anticipated">December 2031</completion_date>
  <primary_completion_date type="Anticipated">December 2030</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>All cause death</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cardiovascular mortality</measure>
    <time_frame>1,6 and 12 months and 5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiovascular mortality</measure>
    <time_frame>1,6 and 12 months and 5 years</time_frame>
    <description>Death due to proximate cardiac cause Death caused by noncoronary vascular condition All procedure-related/surgery-related death All valve-related death Sudden or unwitnessed death Death of unknown cause</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Myocardial infarction</measure>
    <time_frame>1,6 and 12 months and 5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stroke</measure>
    <time_frame>1,6 and 12 months and 5 years</time_frame>
    <description>all stroke and TIA</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bleeding</measure>
    <time_frame>1,6 and 12 months and 5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Operation site complication</measure>
    <time_frame>1,6 and 12 months and 5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vascular access site and access-related complication</measure>
    <time_frame>1,6 and 12 months and 5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Acute kidney injury</measure>
    <time_frame>at a later date between 30 days or discharge</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Event rate of permanent pacemaker insertion</measure>
    <time_frame>1,6 and 12 months and 5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Other TAVR-related complication</measure>
    <time_frame>1,6 and 12 months and 5 years</time_frame>
    <description>Conversion to open surgery Coronary obstruction Mitral valve apparatus damage or dysfunction Cardiac tamponade Endocarditis Valve thrombosis Valve malpositioning TAV-in-TAV deployment(TAV : Transcatheter Aortic Valve)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prosthetic valve dysfunction</measure>
    <time_frame>1,6 and 12 months and 5 years</time_frame>
    <description>Prosthetic aortic valve stenosis Prosthesis-patient mismatch Prosthetic aortic valve regurgitation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Event rate of composite endpoint</measure>
    <time_frame>1,6 and 12 months and 5 years</time_frame>
    <description>Device success Early safety within 30 days Clinical efficacy after 30 days defined as death, stroke, valve dysfunction or heart failure requiring hospitalization, severe dyspnea or valve dysfunction NYHA class III or IV</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Structural valve deterioration</measure>
    <time_frame>1,6 and 12 months and 5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of NYHA class</measure>
    <time_frame>30 days and 1 year</time_frame>
    <description>the New York Heart Association (NYHA) Functional Classification</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of valve area</measure>
    <time_frame>30 days and 1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Free from atrial fibrillation</measure>
    <time_frame>1,6 and 12 months and 5 years</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">6000</enrollment>
  <condition>Aortic Valve Stenosis</condition>
  <arm_group>
    <arm_group_label>all aortic stenosis</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>TAVR</intervention_name>
    <description>All patients who underwent transcatheter aortic valve replacement in Asan medical center, republic of Korea</description>
    <arm_group_label>all aortic stenosis</arm_group_label>
    <other_name>transcatheter aortic valve replacement</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>SAVR</intervention_name>
    <description>All patients who underwent surgical aortic valve replacement in Asan medical center, republic of Korea</description>
    <arm_group_label>all aortic stenosis</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All successful transcatheter aortic valve replacement or surgical aortic valve replacement
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All successful transcatheter aortic valve replacement or surgical aortic valve
             replacement

          -  Written consent

        Exclusion Criteria

          -  Infective endocarditis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Seung-jung Park, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Asan Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Do-yoon Kang, MD</last_name>
    <phone>82230101745</phone>
    <email>kdy1218@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Asan Medical Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Suk-jung Choo, MD</last_name>
      <email>sjchoo@amc.seoul.kr</email>
    </contact>
    <investigator>
      <last_name>Suk-jung Choo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 21, 2017</study_first_submitted>
  <study_first_submitted_qc>September 26, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 2, 2017</study_first_posted>
  <last_update_submitted>December 10, 2017</last_update_submitted>
  <last_update_submitted_qc>December 10, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 12, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Asan Medical Center</investigator_affiliation>
    <investigator_full_name>Suk Jung Choo</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>TAVR</keyword>
  <keyword>TAVI</keyword>
  <keyword>SAVR</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aortic Valve Stenosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

